Anti-MOT1/ SLC16A1/ HHF7 monoclonal antibody

Anti-MOT1/ SLC16A1/ HHF7 antibody for FACS & in-vivo assay

Target products collectionGo to SLC16A1/SLC16A1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T95842-Ab-1/ GM-Tg-hg-T95842-Ab-2Anti-Human SLC16A1 monoclonal antibodyHuman
GM-Tg-rg-T95842-Ab-1/ GM-Tg-rg-T95842-Ab-2Anti-Rat SLC16A1 monoclonal antibodyRat
GM-Tg-mg-T95842-Ab-1/ GM-Tg-mg-T95842-Ab-2Anti-Mouse SLC16A1 monoclonal antibodyMouse
GM-Tg-cynog-T95842-Ab-1/ GM-Tg-cynog-T95842-Ab-2Anti-Cynomolgus/ Rhesus macaque SLC16A1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T95842-Ab-1/ GM-Tg-felg-T95842-Ab-2Anti-Feline SLC16A1 monoclonal antibodyFeline
GM-Tg-cang-T95842-Ab-1/ GM-Tg-cang-T95842-Ab-2Anti-Canine SLC16A1 monoclonal antibodyCanine
GM-Tg-bovg-T95842-Ab-1/ GM-Tg-bovg-T95842-Ab-2Anti-Bovine SLC16A1 monoclonal antibodyBovine
GM-Tg-equg-T95842-Ab-1/ GM-Tg-equg-T95842-Ab-2Anti-Equine SLC16A1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T95842-Ab-1/ GM-Tg-hg-T95842-Ab-2; GM-Tg-rg-T95842-Ab-1/ GM-Tg-rg-T95842-Ab-2;
GM-Tg-mg-T95842-Ab-1/ GM-Tg-mg-T95842-Ab-2; GM-Tg-cynog-T95842-Ab-1/ GM-Tg-cynog-T95842-Ab-2;
GM-Tg-felg-T95842-Ab-1/ GM-Tg-felg-T95842-Ab-2; GM-Tg-cang-T95842-Ab-1/ GM-Tg-cang-T95842-Ab-2;
GM-Tg-bovg-T95842-Ab-1/ GM-Tg-bovg-T95842-Ab-2; GM-Tg-equg-T95842-Ab-1/ GM-Tg-equg-T95842-Ab-2
Products NameAnti-SLC16A1 monoclonal antibody
Formatmab
Target NameSLC16A1
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SLC16A1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species MOT1/ SLC16A1/ HHF7 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLPm001361mouse Slc16a1 Lentivirus plasmid
    ORF Viral VectorvGMLPm001361mouse Slc16a1 Lentivirus particle


    Target information

    Target IDGM-T95842
    Target NameSLC16A1
    Gene ID6566,20501,25027,706593,100009694
    Gene Symbol and SynonymsHHF7,MCT,MCT1,MCT1D,RA™CT1,RNMCT1,SLC16A1
    Uniprot AccessionP53985,P53987
    Uniprot Entry NameMOT1_HUMAN,MOT1_RAT
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000155380
    Target ClassificationN/A

    The target: SLC16A1, gene name: SLC16A1, also named as HHF7, MCT, MCT1, MCT1D. The protein encoded by this gene is a proton-linked monocarboxylate transporter that catalyzes the movement of many monocarboxylates, such as lactate and pyruvate, across the plasma membrane. Mutations in this gene are associated with erythrocyte lactate transporter defect. Alternatively spliced transcript variants have been found for this gene.[provided by RefSeq, Oct 2009].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.